Opinion|Videos|December 9, 2024

NMOSD Management with New FDA-approved Agents to Reduce Relapse and Hospitalization Rates

A panelist discusses how neurologists can adapt their NMOSD management strategies based on recent findings about relapse and hospitalization rates, sharing practical advice and clinical experience for optimizing patient outcomes.

Video content above is prompted by the following:
  • In your clinical practice, how have you adapted your approach to NMOSD management in light of these recent findings on relapse and hospitalization rates?
  • What advice do you have for other neurologists in managing patients with NMOSD and reducing relapse/hospitalization rates?

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Latest CME